Biotech Values

[DewDiligence]

I think we’re on the same wavelength. If the Conatus trial design had been up to me, the trial would’ve had four arms (rather then two) as follows:

• CTI-1027 + SoC
• CTI-1027 + ribavirin
• CTI-1027 monotherapy
• SoC control arm